InspireMD (NSPR) Gross Margin Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -136.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -324.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 311.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 56.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -164.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 124.00 |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn | 1,817.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,817.00 |
| Sep 30, 2025 | 867.00 |
| Jun 30, 2025 | -1,055.00 |
| Mar 31, 2025 | 878.00 |
| Dec 31, 2024 | 276.00 |
| Sep 30, 2024 | 1,428.00 |
| Jun 30, 2024 | -621.00 |
| Mar 31, 2024 | 879.00 |
| Dec 31, 2023 | 27,551.00 |
| Sep 30, 2023 | -226.00 |
| Jun 30, 2023 | 6,811.00 |
| Mar 31, 2023 | 157.00 |
| Dec 31, 2022 | -627.00 |
| Sep 30, 2022 | 1,194.00 |
| Jun 30, 2022 | -449.00 |
| Mar 31, 2022 | 2,790.00 |
| Dec 31, 2021 | -631.00 |
| Sep 30, 2021 | -1,716.00 |
| Jun 30, 2021 | -238.00 |
| Mar 31, 2021 | -1,856.00 |
| Dec 31, 2020 | -27,214.00 |
| Sep 30, 2020 | 910.00 |
| Jun 30, 2020 | -6,131.00 |
| Mar 31, 2020 | 1,552.00 |
| Dec 31, 2019 | 4,296.00 |
| Sep 30, 2019 | 723.00 |
| Jun 30, 2019 | 2,116.00 |
| Mar 31, 2019 | -2,931.00 |
| Dec 31, 2018 | 5,397.00 |
| Sep 30, 2018 | 1,167.00 |
| Jun 30, 2018 | 5,857.00 |
| Mar 31, 2017 | -4,482.00 |
| Sep 30, 2016 | -4,528.00 |
| Jun 30, 2016 | -3,305.00 |
| Mar 31, 2016 | -4,376.00 |
| Dec 31, 2015 | -8,584.00 |
| Sep 30, 2015 | -4,073.00 |
| Mar 31, 2014 | 1,115.00 |
| Sep 30, 2013 | -245.00 |
| Jun 30, 2013 | -271.00 |